NVIDIA
NVDA
Adobe
ADBE
Taiwan Semiconductor
TSM
Disney
DIS
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
CYCC Cyclacel Pharmaceuticals
- 0.3660
- +0.0115+3.24%
Close Dec 30 16:00 ET
- 0.3780
- +0.0120+3.28%
Post 20:01 ET
2.30MMarket Cap-0.01P/E (TTM)
0.3900High0.3231Low1.31MVolume0.3500Open0.3545Pre Close471.18KTurnover21.13%Turnover RatioLossP/E (Static)6.29MShares4.000052wk High-2.38P/B2.27MFloat Cap0.310152wk Low--Dividend TTM6.20MShs Float2141994.0840Historical High--Div YieldTTM18.87%Amplitude0.3101Historical Low0.3590Avg Price1Lot Size
About Cyclacel Pharmaceuticals Company
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. It operates through the United States and United Kingdom geographical segments. The company builds a biopharmaceutical business, which is focused on hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Company Profile
SymbolCYCC
Company NameCyclacel Pharmaceuticals
Listing DateMar 16, 2004
Issue Price8.00
Founded1996
CEOMr. Spiro Rombotis
MarketNASDAQ
Employees12
Fiscal Year Ends12-31
Address200 Connell Drive,Suite 1500
CityBerkeley Heights
ProvinceNew Jersey
CountryUnited States of America
Zip Code07922
Phone1-908-517-7330
Websitehttp://www.cyclacel.com
Company Executives
- Name
- Position
- Salary
- Spiro Rombotis
- Director, President and Chief Executive Officer
- 661.05K
- Paul Mcbarron
- Director, Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer, Chief Operating Officer and Secretary
- 352.62K
- Dr. Brian Schwartz, M.D.
- Director and Interim Chief Medical Officer
- 84.49K
- Dr. Robert J. Spiegel, F.A.C.P.,M.D.
- Vice Chairman of the Board
- 115.99K
- Dr. Christopher S. Henney, D.Sc.,PhD
- Chairman of the Board
- 136.99K
- Dr. Kenneth M. Ferguson, PhD
- Independent Director
- 85.49K
- Dr. Samuel L. Barker,PhD
- Independent Director
- 97.99K
- Karin L. Walker
- Independent Director
- 95.49K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.